Via Nova Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $20M

  • Investors
  • 1

Via Nova Therapeutics General Information

Description

Operator of a biopharmaceutical company intended to develop therapeutics for acute and subacute viral infections. The company designs and develops antiviral programs to target respiratory viruses, including influenza viruses, adenoviruses, rhinoviruses, and human polyomaviruses, and targets mechanisms of viral replication to support the discovery of novel therapeutics, enabling patients to get the treatment for viral infections for which current treatments are lacking and inadequate.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1111 Broadway
  • Suite 1300
  • Oakland, CA 94607
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 1111 Broadway
  • Suite 1300
  • Oakland, CA 94607
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Via Nova Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 07-Sep-2021 $20M Completed Pre-Clinical Trials
To view Via Nova Therapeutics’s complete valuation and funding history, request access »

Via Nova Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-2
Series A-1
To view Via Nova Therapeutics’s complete cap table history, request access »

Via Nova Therapeutics Patents

Via Nova Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024092185-A1 Acyl sulfonamide compounds as inhibitors of polyomavirus Inactive 27-Oct-2022

Via Nova Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Via Nova Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aditum Bio Venture Capital Minority
To view Via Nova Therapeutics’s complete investors history, request access »

Via Nova Therapeutics FAQs

  • When was Via Nova Therapeutics founded?

    Via Nova Therapeutics was founded in 2020.

  • Where is Via Nova Therapeutics headquartered?

    Via Nova Therapeutics is headquartered in Oakland, CA.

  • What is the size of Via Nova Therapeutics?

    Via Nova Therapeutics has 2 total employees.

  • What industry is Via Nova Therapeutics in?

    Via Nova Therapeutics’s primary industry is Drug Discovery.

  • Is Via Nova Therapeutics a private or public company?

    Via Nova Therapeutics is a Private company.

  • What is the current valuation of Via Nova Therapeutics?

    The current valuation of Via Nova Therapeutics is .

  • What is Via Nova Therapeutics’s current revenue?

    The current revenue for Via Nova Therapeutics is .

  • How much funding has Via Nova Therapeutics raised over time?

    Via Nova Therapeutics has raised $20M.

  • Who are Via Nova Therapeutics’s investors?

    Aditum Bio has invested in Via Nova Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process